CAJ | 학술논문

目的探讨e-PTFE在整形外科应用的适应证及其并发症的防治。方法自1997年5月～1999年10月我们在17个不同部位应用不同规格的e-PTFE实施软组织填充术89例。结果89例随访时间1～24个月，其中76例效果满意，13例有并发症，主要是假体外露。结论e-PTFE是一种生物相容性良好的高分子化合物，用于软组织填充有其独到的优点。然而最长随访期仅24个月，因此需要进一步观察其长远效果。
목적탐토e-PTFE재정형외과응용적괄응증급기병발증적방치。방법자1997년5월～1999년10월아문재17개불동부위응용불동규격적e-PTFE실시연조직전충술89례。결과89례수방시간1～24개월，기중76례효과만의，13례유병발증，주요시가체외로。결론e-PTFE시일충생물상용성량호적고분자화합물，용우연조직전충유기독도적우점。연이최장수방기부24개월，인차수요진일보관찰기장원효과。
Objective To investigate the indication of application of expanded polytetrafluoroethylene(Gore Tex e-PTFE Soft Tissue Patch) and prevent its complication in plastic surgery. Method From May 1997 to Oct 1999 we have performed soft tissue augmentation with different types of e-PTFE in 17 different places for 89 cases. Results Postoperative follow-up of 89 cases ranged from 1 to 24 months. Among them 76 cases acquired satisfactory and permanent results. Complications occurred in 13 cases. Main complications were e-PTFE extrusion(7cases). Conclusion e-PTFE is an inert vitreous Teflon alloplast with a high biocompatibility. It creates better results for soft tissue augmentation compared with other materials. Our longest follow-up is 24 months; further study is necessary to evaluate the long-term results and the eventual side effects of e-PTFE.